Is It Time to Buy Biotechnology Stocks?

  • 📰 Investingcom
  • ⏱ Reading Time:
  • 30 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 53%

Canada News News

Canada Canada Latest News,Canada Canada Headlines

Stocks Analysis by Michele Schneider covering: Vertex Pharmaceuticals Inc, Gilead Sciences Inc, iShares Biotechnology ETF, Amgen Inc. Read Michele Schneider's latest article on Investing.com

Furthermore, and even more interesting, is that the ETF does not really reflect the big movers. Rather, IBB is holding as a result but not flying.On the Daily chart, what is not shown here is the July 6-month calendar range low at 124.11.Hence, we feel good calling 124 the bottom of the trading range and risk point.Again, IBB traded above that in early 2023, when it soared to 138.

However, since then, 130-132 has been resistance. We feel good calling that level the top of the trading range. As far as other indicators, Real Motion looks like a double bottom from early July and now, although we would like to see more momentum.Our Leadership indicator shows IBB outperforming SPDR® S&P 500 on a daily timeframe but still underperforming on a weekly basis.437 is the July 6-month calendar range low-will look for a return above or a trip to 420Relative strength here-a return over 346 PositiveOutperformer as all this did was fall to the July range high at 44.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 450. in CA

Canada Canada Latest News, Canada Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Hong Kong stocks fall for seventh day as Japanese stocks gainAsia-Pacific stocks mostly increased Monday, Aug. 21, with shares in Hong Kong declining for the seventh day. Hong Kong stocks dropped, with the Hang Seng...
Source: MarketWatch - 🏆 3. / 97 Read more »